Preferential Allotment - Monitoring Agency Report

4th November, 2026 To, To, The Secretary, The Secretary, Bombay Stock Exchange Ltd (BSE) National Stock Exchange (NSE), Phiroze Jheejheebhoy Towers, Exchange Plaza, Dalal Street, 5th Floor Plot No.C/1, 'G' Block Mumbai - 400 001. Bandra - Kurla Complex Scrip Code - 543308 Mumbai - 400 051. ISIN: INE967H01025 Symbol - KIMS Dear Sir/ Madam Sub: Monitoring Agency Report for the quarter ended September 30, 2026 Ref: Funds raised through Issue of Warrants to the Promoter & Promoter group of the Company. Pursuant to Regulation 32(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Regulation 162A(4) of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, the Monitoring Agency Report for the quarter ended on 30th September, 2026, issued by CARE Ratings Limited, duly reviewed by the Audit Committee of the Company is enclosed herewith. Kindly take the above on your records. Thanking You, Yours truly For Krishna Institute of Medical Sciences Limited Nagajayanthi J. R Company Secretary and Compliance Officer No. CARE/HRO/GEN/2026-27/1024 The Board of Directors Shri B. Bhaskara Rao Managing Director Krishna Institute of Medical Sciences Limited D.No. 1-8-31/1, Minister Road, Secunderabad Telangana - 500003 November 04, 2026 Dear Sir, Monitoring Agency Report for the quarter ended September 30, 2026 in relation to the Preferential Issue of Krishna Institute of Medical Sciences Limited (“the Company” or “KIMS”) We write in our capacity of Monitoring Agency for the Preferential Issue for the amount aggregating to Rs. 600.00 crores of the Company and refer to our duties cast under 162A of the Securities & Exchange Board of India (Issue of Capital & Disclosure Requirements) Regulations. In this connection, we are enclosing the Monitoring Agency Report for the quarter ended September 30, 2026 as per aforesaid SEBI Regulations and Monitoring Agency Agreement dated June 12, 2026. Request you to kindly take the same on records. Thanking you, Yours faithfully, Pritesh Rathi Associate Director Pritesh.Rathi@careedge.in CARE Ratings Limited 401, Ashoka Scintilla, 3-6-520, Himayat Nagar, Corporate Office :4th Floor, Godrej Coliseum, Hyderabad - 500 029 Somaiya Hospital Road, Off Eastern Express Phone: +91-40-4010 2030 Highway, Sion (E), Mumbai - 400 022 Phone: +91-22-6754 3456 • www.careedge.in Page 1 of 9 Report of the Monitoring Agency Name of the issuer: Krishna Institute of Medical Sciences Ltd For quarter ended: September 30, 2026 Name of the Monitoring Agency: CARE Ratings Limited (a) Deviation from the objects: Nil (b) Range of Deviation: Nil Declaration: We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the Companies Act, 2013. The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains and may receive separate compensation for its ratings and certain credit related analyses. We confirm that there is no conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the issuer, or while undertaking credit rating or other commercial transactions with the entity. We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments, where applicable. There are certain sections of the report under the title “Comments of the Board of Directors”, that shall be captured by the Issuer’s Management / Audit Committee of the Board of Directors subsequent to the MA submitting their report to the issuer and before dissemination of the report through stock exchanges. These sections have not been reviewed by the MA, and the MA takes no responsibility for such comments of the issuer’s Management/Board. Signature: Name and designation of the Authorized Signatory: Pritesh Rathi Designation of Authorized person/Signing Authority: Associate Director CARE Ratings Limited 401, Ashoka Scintilla, 3-6-520, Himayat Nagar, Corporate Office :4th Floor, Godrej Coliseum, Hyderabad - 500 029 Somaiya Hospital Road, Off Eastern Express Phone: +91-40-4010 2030 Highway, Sion (E), Mumbai - 400 022 Phone: +91-22-6754 3456 • www.careedge.in Page 2 of 9 1) Issuer Details: Name of the issuer : Krishna Institute of Medical Sciences Limited Name of the promoter : Mr. Bhaskara Rao Bollineni, Mrs. Rajyasri Bollineni, Mr. Abhinay Bollineni and Bluebridge Capital Private Limited Industry/sector to which it belongs : Healthcare 2) Issue Details Issue Period : 18 months (ending in February 18, 2028) from date of allotment (August 19, 2026) Type of issue (public/rights) : Preferential issue of Warrants Type of specified securities : Warrants convertible into equity shares IPO Grading, if any : Not applicable Issue size (in crore) : Rs. 600 crores 3) Details of the arrangement made to ensure the monitoring of issue proceeds: Source of information / Comments of certifications considered by Comments of the Particulars Reply the Board of Monitoring Agency for Monitoring Agency Directors preparation of report The company received ₹150 crore as warrant subscription money during Q2FY27 (August Chartered Accountant certificate*, 2026). No amount was utilised towards the stated utilization certificate from the objects of the issue during the quarter and, Whether all utilization is as per the disclosures in the Offer No comments Yes management^, Bank statement and accordingly, utilisation of the issue proceeds Document? received notice of extraordinary general during Q2FY27 remained nil. The company is yet meeting (EGM) to receive the balance amount of ₹450 crore upon exercise and conversion of the warrants within the stipulated period. CARE Ratings Limited 401, Ashoka Scintilla, 3-6-520, Himayat Nagar, Corporate Office :4th Floor, Godrej Coliseum, Hyderabad - 500 029 Somaiya Hospital Road, Off Eastern Express Phone: +91-40-4010 2030 Highway, Sion (E), Mumbai - 400 022 Phone: +91-22-6754 3456 • www.careedge.in Page 3 of 9 Source of information / Comments of certifications considered by Comments of the Particulars Reply the Board of Monitoring Agency for Monitoring Agency Directors preparation of report Whether shareholder approval has been obtained in case of As confirmed by the issuer’s No comments material deviations# from expenditures disclosed in the Offer Not applicable Nil management received Document? Whether the means of finance for the disclosed objects of the As confirmed by the issuer’s No comments No Nil issue have changed? management received The warrant subscription money of Not Applicable Is there any major deviation observed over the earlier ₹150 crores was received on August No comments as this is the Nil monitoring agency reports? 19, 2026. This is the first Monitoring received first report Agency report Whether all Government/statutory approvals related to the No comments Not applicable Confirmation from management Nil object(s) have been obtained? received Whether all arrangements pertaining to technical No comments Not applicable Confirmation from m [Showing first 8,000 characters — download PDF for full document]